|
|
||||||||
1From the Academic Unit of Ophthalmology, Division of Immunity and Infection, and the 2Department of Endocrinology, Division of Medical Sciences, University of Birmingham, Birmingham, United Kingdom; and the 3Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut.
| Abstract |
|---|
|
|
|---|
METHODS. SGK1 and ENaC subunits were evaluated by in situ hybridization and RT-PCR analysis on human NPE-PE sections and an NPE cell line (ODM-2). Northern blot analyses were conducted on ODM-2 cells incubated with dexamethasone (DEX) or aldosterone (ALDO) and RU38486 (a glucocorticoid receptor [GR] antagonist) or RU26752 (a mineralocorticoid receptor [MR] antagonist) or both inhibitors. The affinity of the GRs and MRs for DEX and ALDO was assessed by radioligand-binding assays.
RESULTS. Expression of SGK1 and ENaC subunits was confirmed in NPE-PE tissues and ODM-2 cells. Dose-dependent induction of SGK1 mRNA in the ODM-2 cells was demonstrated after incubation with DEX or ALDO. While response to DEX was not inhibited by RU38486 or RU26752, there was a moderate reduction in induction by ALDO in the presence of RU26752 that was completely abolished in the presence of both inhibitors. Specific binding of 3[H]DEX and 3[H]ALDO was established, revealing greater expression of GRs than MRs.
CONCLUSIONS. The expression of ENaCs within the NPE-PE and corticosteroid regulation of SGK1 through the GR and MR, indicate that this mechanism may be a feature of sodium transport in the human ocular ciliary epithelium.
This mechanism is analogous to other tissues, such as the kidney and colon, where corticosteroids are known to play a key role in ion and water transport. In these target tissues, the isozyme 11ß-hydroxysteroid dehydrogenase type 2 (11ß-HSD2), protects the mineralocorticoid receptor (MR) from cortisol by inactivation to cortisone,11 thereby allowing aldosterone (ALDO) to bind with high affinity to the MR. The active ligand bound receptor complex translocates to the nucleus where it may dimerize with other ligand-receptor complexes, binding to hormone-response elements, inducing activation of target genes, and thereby initiating transcription and finally synthesis or repression of proteins that are ultimately responsible for the physiological effects of ALDO. One of these target genes is serum and glucocorticoid-regulated kinase (SGK) isoform-112 13 which induces activation of the epithelial sodium channel (ENaC; a heterotetramer consisting of 2
-, 1ß-, and 1
-subunits) and the Na+K+ATPase pump. The sodium transport response to mineralocorticoids is biphasic; an early phase commencing after a latent period of 30 to 45 minutes, with an increased apical membrane permeability mediated through the ENaC, and a late phase of several hours to days, possibly involving de novo synthesis of ENaC and basolateral Na+K+ATPase.14 15 16 17 18 SGK1 has been identified as an early corticosteroid target gene that activates preexisting ENaCs.13 17 19 20 Three isoforms of SGK have been recognized,21 22 all inducing ENaC-mediated apical sodium transport, but only isoform 1 is sensitive to corticosteroids.
Recent studies have demonstrated the presence of the MR, glucocorticoid receptor (GR), and, somewhat surprisingly, 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD1), a cortisol-generating isozyme, within the ocular ciliary epithelium.23 24 25 26 Systemic inhibition of 11ß-HSD1 by carbenoxolone results in a reduction of IOP, providing further evidence that the human eye is a corticosteroid target tissue.26 Furthermore, preliminary data have confirmed expression of the
-ENaC subunit in the ciliary epithelium, and this subunit may be involved in cell volume regulation.27 28 29 In this study we defined expression of SGK1 and ENaC subunits in the human ocular ciliary epithelium and analyzed the corticosteroid regulation of SGK1 at this site using dexamethasone (DEX; a synthetic GR agonist), ALDO (an MR agonist), RU38486 (a GR antagonist), and RU26752 (an MR antagonist).
| Materials and Methods |
|---|
|
|
|---|
Human cortical collecting duct (HCD)31 cells were grown to 90% to 100% confluence in DMEM/F12 with L-glutamine and HEPES (Gibco-Invitrogen Corp.), supplemented with 2% (vol/vol) FCS and insulin-transferrin-selenium.
Tissue Preparation
Paraffin-embedded human ocular sections were obtained from the Academic Unit of Ophthalmology of the University of Birmingham and were managed according to the provisions of the Declaration of Helsinki for the use of human tissue in research. Eyes were acquired at surgical enucleation, and, in all cases, the underlying diagnosis was choroidal malignant melanoma. All sections were stained with hematoxylin and eosin and examined to ensure only adjacent normal anterior segment structures were studied. Using RNase-free conditions, 5-µm-thick sections were cut, floated onto 0.1% diethyl pyrocarbonate (DEPC)-H2O, mounted on poly-L-lysine-coated slides (BDH, Poole, UK) dried overnight at 60°C, and stored in RNase- and dust-free containers until processing.
Generation of SGK1 and ENaC Plasmid DNA Constructs
Human SGK1 cDNA constructs were generated by extracting RNA from a confluent 75-cm2 tissue culture flask of HCD cells with a single-step extraction method (RNAzol B RNA isolation kit; AMS Biotechnology, Oxon, UK) according to the manufacturers protocol. Reverse transcription of RNA was performed using a commercial system (Promega, Southampton, UK). A total of 1 µg RNA was preannealed with 0.75 µg random hexamers by incubation at 70°C for 5 minutes. Primer extension was performed at 37°C for 60 minutes after the addition of reaction buffer, 1 mM of each dNTP, 80 U rRNasin RNase inhibitor and 50 U avian myeloblastosis virus (AMV) reverse transcriptase. A 5-µL aliquot of this reaction was taken for subsequent PCR reactions using primer pairs for human SGK1 (Table 1) . Amplification of a transcript size of 699 bp was performed with an initial denaturing step of 95°C, followed by 35 cycles of 95°C (1 minute), 60°C (1 minute) 72°C (1 minute), and a final elongation step of 72°C for 5 minutes. The reaction product was purified with a DNA purification system (Wizard PCR Preps; Promega), and the SGK1 sequence confirmed with an automated DNA sequencer (Applied Biosystems, Foster City, CA).
|
-, ß-, and
-subunits of the ENaC were generated by transforming full-length sequences of human
-ENaC, ß-ENaC (both previously ligated to the pMT3 vector), and
-ENaC (ligated to the pcDNA3 vector) subunits,32 33 into subcloning-efficiency DH5
-competent cells and amplified, and the plasmid DNA purified with a mini plasmid preparation kit (Totam Biologicals, Northampton, UK). Sequencing provided confirmation of the DNA insert. PCR was performed using a 1:10 dilution of the purified plasmid DNA with 3' and 5' primers designed to cover at least one intronexon boundary for each human ENaC subunit (Table 1) . Amplification of the relevant transcript size was performed using an initial denaturing step of 95°C, followed by 35 cycles of 95°C (1 minute), 54°C (1 minute) 72°C (1 minute), and a final elongation step of 72°C for 5 minutes.
A 5-µL aliquot of each of the SGK1 and ENaC subunit amplified cDNA fragments, were ligated overnight at 4°C to a commercial vector (pGEM-T Easy; Promega), by using the 2x ligation buffer protocol. After transformation and amplification in subcloning-efficiency DH5
-competent cells, plasmid DNA was purified with a mini plasmid preparation kit (Totam Biologicals). Confirmation of the authenticity of the cDNA inserts was provided by DNA sequence analysis.
Generation of SGK1 and ENaC cRNA Probes
ENaC and SGK1 constructs were linearized using appropriate restriction enzymes generating 5' overhangs and purified using the DNA purification system (Wizard PCR Preps; Promega). Antisense and sense complementary RNA probes were synthesized with a digoxigenin (DIG) labeling kit for SP6/T7 polymerase (Roche Molecular Biochemicals, Lewes, UK) and quantified using the DIG-luminescence detection kit (Roche Molecular Biochemicals).
Generation of SGK1 cDNA Probe
The SGK1 insert was digested from the plasmid using EcoRI, resolved on a 1% agarose gel with ethidium bromide, gel purified, and quantified. The SGK1 and 18S-ribosomal cDNAs were labeled with [
-32P]-deoxy-CTP (Amersham Pharmacia Biotech UK, Ltd., Little Chalfont, UK), by using a kit (Megaprime; Roche Molecular Biochemicals).
RT-PCR Analysis of SGK1 and ENaC Subunits in ODM-2 NPE Cells
RNA was extracted from a confluent 75-cm2 tissue culture flask of ODM-2 cells, using a single-step extraction method (RNAzol B RNA isolation kit; AMS Biotechnology) according to the manufacturers protocol. After conducting the reverse-transcriptase reaction just described (generation of SGK1 and ENaC plasmid DNA constructs), a 5-µL aliquot was obtained for subsequent PCR reactions with the primer pairs for SGK1 and ENaC subunits (
, ß, and
) shown in Table 1 . Optimal RT-PCR conditions required a 0.5-µg aliquot of cDNA template, and 0.5 mM MgCl2 for all primer pairs (except the ß-ENaC primer, 2.4 mM MgCl2), and annealing temperatures of 60°C and 54°C for the SGK1 and
-, ß-, and
-ENaC oligonucleotide primer pairs, generating transcript sizes of 699, 601, 1000, and 696 bp, respectively. All thermocycles commenced with an initial denaturation cycle at 95°C for 5 minutes, followed by denaturation, annealing, and extension cycles, terminating with one final extension cycle at 72°C for 5 minutes. Integrity of the RNA was confirmed by 18S ribosomal RNA RT-PCR, and the positive and negative controls were provided by HCD cDNA and nuclease-free water, respectively.
In Situ Hybridization Analysis of SGK1 and ENaC Subunits in Human Ciliary Epithelium
Using RNase-free conditions, in situ hybridization (ISH) was performed on 5-µm paraffin-embedded sections of the anterior segment of six human eyes. Sections were preheated for 4 hours at 60°C, dewaxed, and permeabilized with 20 µg/mL RNase free proteinase K in 50 mM Tris-HCl, at 37°C for 20 minutes. After a rinse in 1x phosphate-buffered saline (PBS), sections were refixed at 4°C with 4% paraformaldehyde in PBS. Hybridization with antisense DIG-labeled cRNA probes (2080 ng/100 µL) was performed at 20°C lower than the melting temperature for each probe for 16 hours in hybridization buffer (2.5x SSC, containing 62.5% deionized formamide [vol/vol] and 12.5% dextran sulfate [wt/vol]) and 120 µg/mL salmon sperm DNA). The sections were rinsed in DEPC-treated water, washed for 10 minutes at 25°C in 2x SSC, for 20 minutes at 50°C in 0.1x SSC, 60 minutes at 50°C in 0.05x SSC and 50% (vol/vol) deionized formamide, and 15 minutes at 25°C in Tris-buffered saline (TBS) with 1% bovine serum albumin (BSA). Hybridized DIG-labeled probes were detected after incubation at 37°C for 1 hour with anti-DIG alkaline phosphatase Fab fragments (750 U/mL) diluted 1:100 in 50 mM Tris-HCl. After final washes at room temperature in TBS-1% BSA, probes were visualized using 4-nitroblue-tetrazolium chloride (NBT) and 5-bromo-4-chloro-3-indolylphosphate (BCIP) chromogen precipitation. To examine the PE in more detail, indirect fluorescence-ISH was performed by incubating the sections at 37°C overnight with 1:6 anti-DIG-fluorescein Fab fragments (Roche Molecular Biochemicals) prepared according to the manufacturers protocol. After final washes at 25°C in PBS-0.5%BSA, the sections were mounted in medium containing 4'6-diamidino-2-phenylindole (DAPI; Vectashield; Vector Laboratories, Peterborough, UK), and visualized with 494-nm (fluorescein) and 360-nm (DAPI) wavelength excitation filters, emitting 523-nm (yellow-green) and 460-nm (blue) fluorescence, respectively. In control experiments, antisense DIG-labeled cRNA probes in a 60-fold excess of unlabeled antisense cRNA probe, sense cRNA probes, or no probe was used.
Corticosteroid Regulation of SGK1 in ODM-2 Cells
Twenty-four hours before experimentation, ODM-2 cells were washed twice with 1x PBS to remove all traces of corticosteroid containing serum, and the medium was replaced with MEM without phenol red, with 1000 mg/mL stabilized glutamine (Glutamax; Gibco-Invitrogen Corp.), supplemented with 10% (vol/vol) charcoal stripped FCS (First Link, (UK) Ltd.) and 2 mM L-glutamine (Gibco-Invitrogen Corp.).
ODM-2 cells were treated with 10-7 M DEX (a synthetic steroid with almost exclusive affinity for GR) or ALDO (high affinity for the MR), diluted in serum-free MEM without phenol red, from a 10-2 M stock steroid solution in 100% ethanol, and incubated at 37°C in 5%CO2. Total RNA was extracted at 0, 30, 60, 120, and 240 minutes after treatment, using the mammalian RNA extraction kit (Gen-Elute; Sigma, Poole, UK) according to the manufacturers protocol, but eluting the final RNA with 20 µL of elution buffer. RNA was stored at -70°C until further analysis.
Time-course experiments were performed to investigate the doseresponse of SGK1 induction, with 10-6, 10-7, 10-8, and 10-9 M DEX or ALDO. To evaluate whether responses were mediated through either the GR or MR, ODM-2 cells were further treated with either 10-7 M DEX or ALDO in the presence of 100-fold excess of a GR antagonist (RU38486, mefipristone; Roussel Uclaf, Roumainville, France), an MR antagonist (RU26752; Roussel Uclaf), or both inhibitors.
Control experiments were performed in a similar manner but with the use of vehicle (100% ethanol) instead of the 10-2 M stock steroid solution, and subsequently diluted with serum-free MEM. All experiments were repeated at least five times.
Northern Blot Analysis
Aliquots of 10 µg denatured RNA were loaded per lane of a denaturing 1.5% formaldehyde-agarose gel and resolved by electrophoresis at 125 V for 3 to 4 hours, before transfer onto nylon filters (Hybond N+; Roche Molecular Biochemicals) overnight. After fixation by 254 nm UV irradiation, filters were incubated for 5 hours in prehybridization buffer containing 0.77 M sodium phosphate (pH7.2; 0.2 M NaH2PO4.H2O+0.58 M Na2HPO4) and 0.5 mM EDTA, 7% SDS (wt/vol), and 100 µg/mL denatured salmon sperm DNA (Sigma) and hybridized (18 hours) at 65°C with 32P-labeled SGK1 cDNA. Filters were washed to a final stringency of 0.3x SSC and 0.1% SDS at 55°C before autoradiography at -70°C for 2 days to 1 week. Filters were then stripped by adding a boiling solution of 0.1% SSC and 0.1% SDS directly onto the membrane, allowing the membrane to cool to room temperature on an orbital shaker, and repeating. This was followed by prehybridization and hybridization with 32P-18S rRNA cDNA for 12 hours and washing to a final stringency of 0.1% SSC and 0.1% SDS at 65°C, before autoradiography at room temperature for 1 to 2 hours.
Densitometry was performed by capturing an image of the autoradiograph on computer (Gene Genius Bio-imaging System and Genesnap 4; Syngene-Synoptics, Ltd., Cambridge, UK) computer software. Quantification of the signal was also performed on computer (Genetools 3; Syngene-Synoptics Ltd.) and the data exported to a spreadsheet program (Excel 2000; Microsoft Corp., Redmond, WA) and a statistical analysis program (Minitab 13.1 Windows; Minitab Inc., State College, PA) for further analysis: expression of SGK1 mRNA was normalized to expression of 18S mRNA, and standardized to the baseline expression at time 0; SGK1 mRNA induction was compared for each time point, to baseline expression at time 0, by analysis of variance.
Radioligand-Binding Assays
The capacity of glucocorticoid and mineralocorticoid binding was assessed by radiolabeled steroid binding assays, as previously described.34 ODM-2 cells were grown to 80% to 90% confluence in 75-cm2 tissue culture flasks, trypsinized, washed twice with 1x PBS, and resuspended in serum-free medium to achieve 5 x 106 cells/mL. Aliquots (200 µL) of the cell suspension (1 x 106 cells), were added to glass tubes containing increasing concentrations (0.120 nM) of (1) [3H]DEX (specific activity 89 Ci/mmol, Amersham Pharmacia Biotech UK, Ltd.); (2) [3H]DEX and a 200-fold excess of unlabeled DEX; (3) [3H]ALDO (specific activity 56 Ci/mmol, Amersham Pharmacia Biotech UK, Ltd.); (4) [3H]ALDO and a 200-fold excess of unlabeled ALDO; or (5) [3H]DEX and a 200-fold excess of RU38486.
Cells were incubated with the radiolabeled steroids for 1 hour at 37°C in 5%CO2, washed twice with 500 µL of 1x PBS at 4°C, and centrifuged at 1500 rpm at 4°C for 10 minutes. This was followed by a final wash with 500 µL of 4°C lysis buffer (sucrose 0.25 M, Tris 0.02 M, Triton X-100 0.5% [vol/vol]; pH 7.4), and the final pellet was resuspended with 200 µL of 1x PBS at 4°C and 500 µL of absolute ethanol at 4°C. Bound radioactivity was analyzed by scintillation counting, and assays for Scatchard plots were performed in duplicate and repeated at least three times. Data were linearized by plotting specifically bound hormone divided by free hormone (total minus specifically bound hormone). The slope of the resultant Scatchard plot corresponded to the binding affinity value (dissociation constant, Kd), and the intercept with the x-axis corresponded to the total saturable binding value (maximal binding capacity, Bmax). By using the latter together with the Avogadro constant, it was possible to determine the number of GRs or MRs per cell.
| Results |
|---|
|
|
|---|
|
|
RT-PCR Analysis of SGK1 and ENaC Subunits in ODM-2 NPE Cells
SGK1 and
-, ß-, and
-ENaC subunit mRNA species were consistently identified in the ODM-2 NPE cells (Fig. 3) .
|
|
|
|
Control experiments performed by substituting the steroid for vehicle revealed no induction of SGK1 mRNA (Fig. 4C) .
Analysis of GR and MR Expression in the ODM-2 Cells
ODM-2 NPE cells showed specific binding of both [3H]DEX and [3H]ALDO (Fig. 7A) . Scatchard analysis of the binding kinetics showed that the Bmax for [3H]DEX (34,000 GRs per cell) was greater than that for [3H]ALDO (4,200 MRs per cell). The mean Kds were 8.1 x 10-9 and 3.6 x 10-9 M for the GRs and MRs, respectively. Saturation binding kinetics comparing [3H]DEX binding in the presence of a 200-fold excess of unlabeled DEX or RU38486, confirmed the specificity of binding with both agents displacing [3H]DEX from GR (Fig. 7B) .
|
| Discussion |
|---|
|
|
|---|
-ENaC subunit, have been localized to the ocular ciliary epithelium.23 24 25 26 Studies in vitro suggest that the
-ENaC subunit may have a role in sodium reabsorption by the NPE,29 a phenomenon less widely investigated than sodium secretion into the posterior chamber. Studies in vivo performed on rabbits have demonstrated increased IOP after administration of ALDO and decreased IOP after spironolactone (an MR antagonist)35 and mefipristone (RU38486, a GR antagonist),36 whereas in human studies, IOP has been shown to decline after carbenoxolone (an inhibitor of 11ß-HSD).26 Using ISH, we have successfully demonstrated expression of the
-ENaC subunit and have also defined expression of the ß- and
-ENaC subunits and SGK1 mRNAs to both the NPE, and by indirect fluorescence-ISH, the PE cytoplasm, although the full extent of expression at this latter site was masked by pigment granules. RT-PCR analysis confirmed expression of SGK1 and ENaC subunit in the ODM-2 NPE cultured cells These data support the potential for corticosteroid regulatory mechanisms as possible contributors to the net secretion of sodium and aqueous humor formation.
The ENaC is a heterotetramer consisting of three subunits (
, ß, and
) in a ratio of 2:1:1. Expression of all subunits is needed for full activation of the channels, although expression of the
-ENaC subunit alone or in combination with the ß- or
-ENaC leads to generation of a small sodium flux.32 33 ENaC activity is induced by mineralocorticoids, and it is thought that the initial early sodium response is mediated through mechanisms such as direct phosphorylation of one or more of the ENaC subunits37 or interaction with neuronal precursor cells expressed developmental downregulated 4 (Nedd4)38 that increases ENaC stability at the cell surface. SGK1 plays a key role in ENaC function by increasing sodium flux and cell surface expression, but to date direct phosphorylation of the ENaC subunits by SGK1 has not been demonstrated. Nevertheless, a recent study has shown that SGK1 phosphorylates the Nedd4 intermediary protein, thereby regulating ENaC cell surface activity and expression.39 Subsequent ubiquitination of the ENaC-Nedd4 complex facilitates endocytosis and eventual lysosomal degradation.38 ENaC turnover is rapid, with a reported half-life of 40 to 120 minutes.38 40 As a result, ENaC subunits are almost undetectable by immunohistochemistry at the apical membrane in the absence of prior ALDO stimulation,18 41 whereas expression has been more successfully demonstrated by ISH both in cultured cells and tissues, or by fluorophore-labeled techniques.13 20 42
SGK1, a member of the serine-threonine protein kinase family, was first characterized as a glucocorticoid and serum regulated mRNA in a rat mammary epithelial tumor cell line.12 SGK1 mRNA levels are strongly and rapidly induced by a variety of regulators, including ALDO, DEX, follicle-stimulating hormone,43 vitamin D,44 osmotic stress,45 insulin, transforming growth factor-ß,46 and SGK1-immunoreactive protein has been shown to be induced, peaking 6 hours after incubation with corticosteroids.13
We have confirmed induction of SGK1 mRNA by both DEX and ALDO in ODM-2 sodium-transporting human NPE cells, reaching a peak at 60 minutes. A dose-dependent induction was observed in response to ALDO that was reduced with the MR antagonist, RU26752. The response was completely abolished in the presence of both inhibitors. Radiolabeled ligand-binding assays in the ODM-2 cells confirmed the presence of MR and GR, but MR expression was less than 15% that of the GR (4,200 MRs per cell compared with 34,000 GRs per cell). These data suggest that ALDO induces SGK1 mRNA through a classic steroid nuclear receptor involving the MRs, binding to nuclear chromatin most probably as a homodimer (MR-MR), but also as a heterodimer (GR-MR). The likelihood of corticosteroid receptor heterodimerization and target gene interaction is tissue specific, depending on the GR-to-MR ratio.47 48 In the case of the ODM-2 cells, the ratio was 8:1, suggesting that one of the mechanisms by which ALDO induces SGK1 mRNA may be through heterodimerization.
The induction of SGK1 mRNA by DEX is more difficult to explain. There was a clear dose response to the DEX, but this response was not fully inhibited by RU38486, RU26752, or both inhibitors. DEX is a synthetic steroid and a potent ligand for the GR, with minimal affinity for the MR. As Scatchard analysis confirmed functionally active corticosteroid receptors in the ODM-2 cells and maximal saturation binding kinetics confirmed inhibition of DEX binding to the GR by RU38486, the failure of RU38486 to block SGK1 mRNA induction by DEX is puzzling. Furthermore, a functional hormone response element has been defined in the SGK1 promoter, and DEX has been shown to mediate SGK1 transcription through this promoter within 15 minutes of steroid treatment.49 The similarity in time course observed with ALDO and DEX suggests that an effect on SGK1 mRNA stability cannot account for the DEX-induced effect. Further studies are needed to define this apparent promiscuous effect of DEX on SGK1 mRNA levels. One explanation of our findings could be partly dependent on the rapid non-nuclear action of corticosteroid hormones that seems to be particularly important in the role of glucocorticoids in neural function (neurotransmitters, second-messenger systems, modulation of mood, and behavior) and also in glucocorticoid-mediated immune function.50 51 A two-step model for corticosteroid action has been developed in an attempt to explain early (<10 minutes) and late (>10 minutes) cellular responses to corticosteroids and consists of both rapid nongenomic and classic genomic modes of steroid action. In this model, it is proposed that the nongenomic pathway of steroid action involves membrane receptors, intracellular second messengers, and effector systems at the level of the plasma membrane. In addition, nuclear steroid-receptor complexinitiated nuclear transcription and protein synthesis are modulated by nongenomic signaling cascades and ion transporter activities, and thus may be especially relevant in the physiological effects of mineralocorticoids.52 53 54 It remains to be seen whether the DEX-mediated induction of SGK1 mRNA in ODM-2 cells is dependent in part, on non-nuclear mechanisms or on as yet uncharacterized mechanisms.
In summary, we have demonstrated expression and corticosteroid regulation of SGK1 mRNA and the ENaC subunits in the human ocular ciliary epithelium. The induction of SGK1 mRNA by ALDO appears to involve the MR, whereas induction by DEX appears to be mediated partly through GRs (or MRs), but possibly through additional nongenomic or uncharacterized routes. The corticosteroid regulation of SGK1 through GRs and MRs and expression of ENaC within the NPE-PE indicate that this mechanism may be an integral feature of sodium transport signaling cascade in the human ocular ciliary epithelium.
| Footnotes |
|---|
Supported by the Medical Research Council, United Kingdom, and the Research in Eye Disease Trust, United Kingdom.
Submitted for publication May 28, 2002; revised October 17, 2002; accepted December 6, 2002.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Paul M. Stewart, Endocrinology, Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK; p.m.stewart{at}bham.ac.uk.
| References |
|---|
|
|
|---|
, ß, and
subunit proteins in the rat kidney J Clin Invest 104,R19-R23
-subunits of the human epithelial sodium channel Am J Physiol 268,C1157-C1163
, 25-dihydroxyvitamin D3 and its analog EB1089 under growth inhibitory conditions in squamous carcinoma cells Mol Endocrinol 15,1127-1139This article has been cited by other articles:
![]() |
H. Caohuy, C. Jozwik, and H. B. Pollard Rescue of {Delta}F508-CFTR by the SGK1/Nedd4-2 Signaling Pathway J. Biol. Chem., September 11, 2009; 284(37): 25241 - 25253. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lang, C. Bohmer, M. Palmada, G. Seebohm, N. Strutz-Seebohm, and V. Vallon (Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms. Physiol Rev, October 1, 2006; 86(4): 1151 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. U Onyimba, N. Vijapurapu, S J. Curnow, P. Khosla, P. M Stewart, P. I Murray, E. A Walker, and S. Rauz Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye. J. Endocrinol., August 1, 2006; 190(2): 483 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J S Langman, R J Lancashire, K K Cheng, and P M Stewart Systemic hypertension and glaucoma: mechanisms in common and co-occurrence Br J Ophthalmol, August 1, 2005; 89(8): 960 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rauz, C.M.G. Cheung, P.J. Wood, M. Coca-Prados, E.A. Walker, P.I. Murray, and P.M. Stewart Inhibition of 11{beta}-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension QJM, July 1, 2003; 96(7): 481 - 490. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |